XCR1

Mice Rats Animals Th1 Cells Probucol / metabolism Ventricular Remodeling Heart Diseases / metabolism Dendritic Cells Heart Injuries / metabolism
CXCR3 chemokine signal Flow cytometry Ischemic cardiac remodeling Th1 XCR1(+) cDC1

Journal

Journal of molecular and cellular cardiology
ISSN: 1095-8584
Titre abrégé: J Mol Cell Cardiol
Pays: England
ID NLM: 0262322

Informations de publication

Date de publication:
03 2023
Historique:
received: 21 08 2022
revised: 02 01 2023
accepted: 24 01 2023
pubmed: 6 2 2023
medline: 14 3 2023
entrez: 5 2 2023
Statut: ppublish

Résumé

Cardiac remodeling has no established therapies targeting inflammation. CD4

Identifiants

DOI: 10.1016/j.yjmcc.2023.01.011 PMID: 36739942
pubmed: 36739942
pii: S0022-2828(23)00017-2
doi: 10.1016/j.yjmcc.2023.01.011
pii:
doi:

Substances chimiques

Probucol P3CTH044XJ

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

68-83

Informations de copyright

Copyright © 2023 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Auteurs

Hiroyasu Inui (H)

Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Japan.

Makoto Nishida (M)

Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Japan; Health and Counseling Center, Osaka University, Suita, Japan. Electronic address: makoton@cardiology.med.osaka-u.ac.jp.

Michiko Ichii (M)

Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Suita, Japan.

Hajime Nakaoka (H)

Nakaoka clinic, Kakogawa, Japan.

Masumi Asaji (M)

Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Japan.

Seiko Ide (S)

Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Japan; Health and Counseling Center, Osaka University, Suita, Japan.

Shigeyoshi Saito (S)

Division of Health Sciences, Department of Medical Physics and Engineering, Osaka University Graduate School of Medicine, Suita, Japan.

Ayami Saga (A)

Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Japan.

Takashi Omatsu (T)

Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Japan.

Katsunao Tanaka (K)

Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Japan.

Kotaro Kanno (K)

Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Japan.

Jiuyang Chang (J)

Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Japan.

Yinghong Zhu (Y)

Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Japan.

Takeshi Okada (T)

Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Japan.

Daisuke Okuzaki (D)

Genome Information Research Center, Research Institute for Microbial Diseases, Osaka University, Suita, Japan; Integrated Frontier Research for Medical Science Division, Institute for Open and Transdisciplinary Research Initiatives (OTRI), Osaka University, Suita, Japan.

Takahiro Matsui (T)

Department of Pathology, Graduate School of Medicine, Osaka University, Suita, Japan.

Tohru Ohama (T)

Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Japan; Department of Dental Anesthesiology, Osaka University Graduate School of Dentistry, Suita, Japan.

Masahiro Koseki (M)

Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Japan.

Eiichi Morii (E)

Department of Pathology, Graduate School of Medicine, Osaka University, Suita, Japan.

Naoki Hosen (N)

Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Suita, Japan; Integrated Frontier Research for Medical Science Division, Institute for Open and Transdisciplinary Research Initiatives (OTRI), Osaka University, Suita, Japan; Laboratory of Cellular Immunotherapy, World Premier International Immunology Frontier Research Center, Osaka University, Suita, Japan.

Shizuya Yamashita (S)

Rinku General Medical Center, Izumisano, Japan.

Yasushi Sakata (Y)

Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Japan.

Articles similaires

Evaluating the efficacy of telesurgery with dual console SSI Mantra Surgical Robotic System: experiment on animal model and clinical trials.

Sudhir Prem Srivastava, Vishwajyoti Pascual Srivastava, Avinesh Singh et al.
1.00
Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell

FBXO22 inhibits colitis and colorectal carcinogenesis by regulating the degradation of the S2448-phosphorylated form of mTOR.

Minle Li, Xuan Chen, Pengfei Qu et al.
1.00
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice

Use of organic material provided by an automatic enrichment device by weaner pigs and its influence on tail lesions.

Philipp Heseker, Jeanette Probst, Stefanie Ammer et al.
1.00
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Rodentia › Muridae › Murinae › Souris › XCR1
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Rodentia › Muridae › Murinae › Rats › XCR1
questionsmedicales.fr › Eucaryotes › Animaux › XCR1
questionsmedicales.fr › Systèmes sanguin et immunitaire › Système immunitaire › Leucocytes › Agranulocytes › Lymphocytes › Lymphocytes T › Sous-populations de lymphocytes T › Lymphocytes T auxiliaires › Lymphocytes auxiliaires Th1 › XCR1
questionsmedicales.fr › Composés chimiques organiques › Hydrocarbures › Hydrocarbures cycliques › Hydrocarbures aromatiques › Dérivés du benzène › Phénols › Probucol › XCR1
questionsmedicales.fr › Phénomènes physiologiques respiratoires et circulatoires › Phénomènes physiologiques cardiovasculaires › Fonction ventriculaire › Remodelage ventriculaire › XCR1
questionsmedicales.fr › Maladies cardiovasculaires › Cardiopathies › XCR1
questionsmedicales.fr › Systèmes sanguin et immunitaire › Système immunitaire › Système phagocytaire mononucléé › Cellules dendritiques › XCR1
questionsmedicales.fr › Plaies et blessures › Blessures du thorax › Lésions traumatiques du coeur › XCR1